Roth MKM Reiterates Buy on Tenax Therapeutics, Maintains $30 Price Target
Tenax Therapeutics Analyst Ratings
Tenax Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Tenax Therapeutics (TENX) and Day One Biopharmaceuticals (DAWN)
Roth MKM Initiates Coverage On Tenax Therapeutics With Buy Rating, Announces Price Target of $6
Tenax Therapeutics (TENX) Receives a Buy From H.C. Wainwright
No Data